| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 20.12% | Barclays | $5 → $4 | Maintains | Underweight |
| 09/26/2023 | 140.24% | B of A Securities | → $8 | Reinstates | → Buy |
| 08/17/2023 | 350.45% | Citigroup | $18 → $15 | Maintains | Buy |
| 08/08/2023 | 50.15% | Barclays | $6 → $5 | Maintains | Underweight |
| 08/07/2023 | 170.27% | RF Lafferty | $10 → $9 | Maintains | Buy |
| 07/13/2023 | 20.12% | Morgan Stanley | $4 → $4 | Reiterates | Underweight → Underweight |
| 06/08/2023 | 80.18% | Wolfe Research | → $6 | Downgrades | Peer Perform → Underperform |
| 05/10/2023 | 260.36% | RF Lafferty | $15 → $12 | Maintains | Buy |
| 02/28/2023 | 350.45% | RF Lafferty | $17 → $15 | Maintains | Buy |
| 02/28/2023 | — | Needham | Reinstates | → Hold | |
| 02/15/2023 | 80.18% | Barclays | → $6 | Initiates Coverage On | → Underweight |
| 01/26/2023 | 20.12% | Morgan Stanley | $8 → $4 | Maintains | Underweight |
| 01/25/2023 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 11/30/2022 | 350.45% | Evercore ISI Group | → $15 | Initiates Coverage On | → Outperform |
| 11/15/2022 | 140.24% | Morgan Stanley | $10 → $8 | Maintains | Equal-Weight |
| 11/03/2022 | 140.24% | RBC Capital | $13 → $8 | Downgrades | Overweight → Sector Weight |
| 09/15/2022 | 260.36% | Needham | → $12 | Initiates Coverage On | → Buy |
| 08/11/2022 | 200.3% | Exane BNP Paribas | $12 → $10 | Downgrades | Outperform → Neutral |
| 08/05/2022 | 200.3% | Morgan Stanley | $15 → $10 | Downgrades | Overweight → Equal-Weight |
| 07/14/2022 | 350.45% | Morgan Stanley | $20 → $15 | Maintains | Overweight |
| 05/25/2022 | 290.39% | Tudor Pickering | $25 → $13 | Downgrades | Buy → Hold |
| 05/18/2022 | 500.6% | Morgan Stanley | $30 → $20 | Maintains | Overweight |
| 05/17/2022 | 500.6% | Credit Suisse | $25 → $20 | Maintains | Outperform |
| 05/05/2022 | 320.42% | Barclays | $16 → $14 | Maintains | Equal-Weight |
| 05/05/2022 | 320.42% | RBC Capital | $19 → $14 | Maintains | Outperform |
| 05/05/2022 | 710.81% | Citigroup | $29 → $27 | Maintains | Buy |
| 04/11/2022 | — | Exane BNP Paribas | Initiates Coverage On | → Outperform | |
| 02/18/2022 | 380.48% | Barclays | $18 → $16 | Maintains | Equal-Weight |
| 02/17/2022 | 770.87% | Citigroup | $30 → $29 | Maintains | Buy |
| 02/17/2022 | 470.57% | RBC Capital | $26 → $19 | Maintains | Outperform |
| 02/17/2022 | 650.75% | Credit Suisse | $32 → $25 | Maintains | Outperform |
| 11/18/2021 | 740.84% | Cowen & Co. | $24 → $28 | Maintains | Outperform |
| 11/09/2021 | 860.96% | Credit Suisse | → $32 | Initiates Coverage On | → Outperform |
| 09/23/2021 | 470.57% | Tudor Pickering | → $19 | Initiates Coverage On | → Buy |
| 09/16/2021 | 440.54% | B of A Securities | $27 → $18 | Downgrades | Buy → Neutral |
| 08/10/2021 | 1101.2% | Morgan Stanley | → $40 | Initiates Coverage On | → Overweight |
| 08/09/2021 | 380.48% | Barclays | $17 → $16 | Maintains | Equal-Weight |
| 08/06/2021 | 680.78% | RBC Capital | $27 → $26 | Maintains | Outperform |
| 06/09/2021 | 710.81% | RBC Capital | → $27 | Initiates Coverage On | → Outperform |
| 04/22/2021 | 200.3% | Goldman Sachs | $15 → $10 | Downgrades | Neutral → Sell |
| 04/20/2021 | 830.93% | B of A Securities | → $31 | Initiates Coverage On | → Buy |
| 04/01/2021 | 410.51% | Barclays | → $17 | Initiates Coverage On | → Equal-Weight |
| 03/03/2021 | 800.9% | Wolfe Research | $21 → $30 | Upgrades | Underperform → Peer Perform |
| 03/01/2021 | 1101.2% | Morgan Stanley | $27 → $40 | Maintains | Overweight |
| 02/26/2021 | 1101.2% | Morgan Stanley | $27 → $40 | Maintains | Overweight |
| 02/12/2021 | 710.81% | Morgan Stanley | → $27 | Initiates Coverage On | → Overweight |
| 01/22/2021 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 12/11/2020 | 350.45% | Goldman Sachs | → $15 | Initiates Coverage On | → Neutral |
| 12/10/2020 | 380.48% | Wolfe Research | → $16 | Initiates Coverage On | → Underperform |
| 11/25/2020 | 680.78% | Citigroup | → $26 | Initiates Coverage On | → Buy |
| 11/09/2020 | 560.66% | Cowen & Co. | → $22 | Initiates Coverage On | → Outperform |
What is the target price for Fisker (FSR)?
The latest price target for Fisker (NYSE: FSR) was reported by Barclays on November 14, 2023. The analyst firm set a price target for $4.00 expecting FSR to rise to within 12 months (a possible 20.12% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fisker (FSR)?
The latest analyst rating for Fisker (NYSE: FSR) was provided by Barclays, and Fisker maintained their underweight rating.
When is the next analyst rating going to be posted or updated for Fisker (FSR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fisker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fisker was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
Is the Analyst Rating Fisker (FSR) correct?
While ratings are subjective and will change, the latest Fisker (FSR) rating was a maintained with a price target of $5.00 to $4.00. The current price Fisker (FSR) is trading at is $3.33, which is out of the analyst's predicted range.